Quarterly report pursuant to Section 13 or 15(d)

WARRANTS

v3.19.2
WARRANTS
3 Months Ended
Jun. 30, 2019
WARRANTS  
WARRANTS

12.       WARRANTS

The following is a continuity schedule of the Company’s common share purchase warrants:

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

Average

 

 

Number of

 

Exercise Price 

 

 

 Warrants

 

($)

Outstanding and exercisable, March 31, 2018 and June 30, 2018

    

365,974

    

53.19

Issued in connection with anti-dilution provision connected  warrant transaction

 

67,952

 

55.71

Issued in connection with anti-dilution provision connected  warrant transaction

 

6,305

 

34.50

Issued in connection with anti-dilution provision connected  warrant transaction

 

52,590

 

38.91

Expired

 

(204,304)

 

(51.85)

Outstanding and exercisable, March 31, 2019

 

288,517

 

40.27

Expired

 

(163,483)

 

(38.91)

Outstanding and exercisable June 30, 2019

 

125,034

 

20.07

 

During the quarter ended June 30, 2019, 163,483 warrants expired in accordance with their terms (June 30, 2018 – Nil)

Common share purchase warrants

The following is a summary of common share purchase warrants outstanding after the warrant offer to amend the additional warrant issue and the re-pricing of the warrants as of June 30, 2019.

 

 

 

 

 

 

Exercise 

    

Number of 

    

 

Price ($)

 

Warrants

 

Expiry Date

90.00

 

15,658

 

March 31, 2023

37.50

 

2,667

 

June 27, 2020

9.375

 

64,025

 

August 14, 2022

9.375

 

42,684

 

March 31, 2022

 

 

125,034

 

 

 

The weighted-average remaining contractual term of the outstanding warrants was 3.07 years (June 30, 2018 -  2.01 years).